Life ScienceCompany
Unither Pharmaceuticals M&A Summary
Unither Pharmaceuticals has acquired 2 companies of its own, including 1 in the last 5 years.
Unither Pharmaceuticals has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).
Unither Pharmaceuticals Ownership
Who owns Unither Pharmaceuticals?
Unither Pharmaceuticals is owned by GIC, IK Partners, Keensight Capital, NiXEN Partners and Parquest Capital. It was acquired on October 26, 2022.
Is Unither Pharmaceuticals PE-backed?
Yes. Unither Pharmaceuticals is owned by private equity investors GIC, IK Partners, Keensight Capital, NiXEN Partners and Parquest Capital.
Was Unither Pharmaceuticals formerly PE-backed?
Yes. Unither Pharmaceuticals was formerly owned by 7 private investors.
Unither Pharmaceuticals Business Overview
Where is Unither Pharmaceuticals headquartered?
Unither Pharmaceuticals is headquartered in Amiens, France.
What is Unither Pharmaceuticals’ revenue?
Unither Pharmaceuticals disclosed revenue of 330M EUR for 2018 and 180M EUR for 2005.
How many employees does Unither Pharmaceuticals have?
Unither Pharmaceuticals has 1,500 employees.
What sector is Unither Pharmaceuticals in?
Unither Pharmaceuticals is a life science company.
When was Unither Pharmaceuticals founded?
Unither Pharmaceuticals was founded in 1993.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
Unlimited Searches
